August 16, 2017
CSRF Recommends Insightful Books About Cushing’s Disease
News
The Cushing’s Support and Research Foundation (CSRF) is calling attention to three books of potential interest to Cushing’s Disease ... Read more
August 11, 2017August 11, 2017
Ortho Clinical Diagnostics Announces FDA Clearance of New Insulin Assay
News
Ortho Clinical Diagnostics, a producer of in vitro diagnostics, has announced that Ortho’s Vitros Immunodiagnostic Products Insulin Reagent and ... Read more
August 7, 2017August 7, 2017
Researchers Recruiting Cushing’s Disease Patients for Osilodrostat Phase 3 Trial
News
A new Phase 3 clinical trial (NCT02697734) is actively recruiting Cushing’s disease patients in several countries to test the ... Read more
July 31, 2017July 31, 2017
Cancer Treatment May Inhibit ACTH Overexpression, Preventing Cushing’s Disease
News
The recent identification of genetic mutations linked to Cushing disease (CD) and its unbalanced molecular mechanisms has opened new ... Read more
July 21, 2017
Signifor May be Safe, Effective Option to Treat Cushing’s Long-term, Study Indicates
News
Signifor (pasireotide), an approved therapy for Cushing’s disease, has shown promise as a long-term treatment for ... Read more
July 18, 2017July 18, 2017
Cushing’s Related Tumors Require Lymph Vessel Growth for Steroid Production, Study Suggests
News
Aggressive adrenocortical carcinomas differ from tumors linked to Cushing’s syndrome in the density of blood and lymph vessels, according ... Read more
July 13, 2017
Researchers Identify Gene Mutations Likely Promoting Pituitary Tumor Growth in Cushing’s Disease
News
Mutations in a gene called CABLES1 might contribute to pituitary tumor growth in people with Cushing’s disease, according to ... Read more
June 29, 2017June 29, 2017
Verona Gets Green Light to Enroll Patients in European Trial of COPD Therapy RPL554
News
Five European countries have agreed to Verona Pharma’s plan to begin enrolling patients in a Phase 2b clinical trial of RPL554 as a ... Read more
June 27, 2017June 27, 2017
UK’s National Health Service Approves Daxas as Treatment for COPD
News
The United Kingdom’s National Institute for Health and Care Excellence (NICE) recently approved Daxas (roflumilast), developed by AstraZeneca, ... Read more
June 22, 2017June 22, 2017
$10M NIH Grant Aims to Identify Genes Linked to COPD, Other Diseases
News
The National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health has granted $10 million to the ... Read more

CSRF Recommends Insightful Books About Cushing’s Disease

The Cushing’s Support and Research Foundation (CSRF) is calling attention to three books of potential interest to Cushing’s Disease patients and to healthcare providers who treat the relatively rare ... Read more

August 11, 2017August 11, 2017

Ortho Clinical Diagnostics Announces FDA Clearance of New Insulin Assay

News

Ortho Clinical Diagnostics, a producer of in vitro diagnostics, has announced that Ortho’s Vitros Immunodiagnostic Products Insulin Reagent and Calibrators have received 510(k) clearance from the U.S. Food and ... Read more

August 7, 2017August 7, 2017

Researchers Recruiting Cushing’s Disease Patients for Osilodrostat Phase 3 Trial

News

A new Phase 3 clinical trial (NCT02697734) is actively recruiting Cushing’s disease patients in several countries to test the safety and effectiveness of the investigational therapy osilodrostat (LCI699). The ... Read more

July 31, 2017July 31, 2017

Cancer Treatment May Inhibit ACTH Overexpression, Preventing Cushing’s Disease

News

The recent identification of genetic mutations linked to Cushing disease (CD) and its unbalanced molecular mechanisms has opened new potential therapeutic avenues for an illness with a large unmet ... Read more

July 21, 2017

Signifor May be Safe, Effective Option to Treat Cushing’s Long-term, Study Indicates

News

Signifor (pasireotide), an approved therapy for Cushing’s disease, has shown promise as a long-term treatment for some patients with the disease, according to results of an extension study of ... Read more

July 18, 2017July 18, 2017

Cushing’s Related Tumors Require Lymph Vessel Growth for Steroid Production, Study Suggests

News

Aggressive adrenocortical carcinomas differ from tumors linked to Cushing’s syndrome in the density of blood and lymph vessels, according to a research team at Portugal’s University of Porto. Their ... Read more

July 13, 2017

Researchers Identify Gene Mutations Likely Promoting Pituitary Tumor Growth in Cushing’s Disease

News

Mutations in a gene called CABLES1 might contribute to pituitary tumor growth in people with Cushing’s disease, according to a study that suggests the gene normally acts as a ... Read more

June 29, 2017June 29, 2017

Verona Gets Green Light to Enroll Patients in European Trial of COPD Therapy RPL554

News

Five European countries have agreed to Verona Pharma’s plan to begin enrolling patients in a Phase 2b clinical trial of RPL554 as a maintenance treatment for chronic obstructive pulmonary disease, or COPD. The ... Read more

June 27, 2017June 27, 2017

UK’s National Health Service Approves Daxas as Treatment for COPD

News

The United Kingdom’s National Institute for Health and Care Excellence (NICE) recently approved Daxas (roflumilast), developed by AstraZeneca, as a treatment for chronic obstructive pulmonary disease (COPD). The new indication could ... Read more

June 22, 2017June 22, 2017

$10M NIH Grant Aims to Identify Genes Linked to COPD, Other Diseases

News

The National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health has granted $10 million to the McDonnell Genome Institute at Washington University to investigate and identify ... Read more